EMA/PE/0000221772
Submitted by Anonymous (not verified) on 16 December 2025 - 10:54
EMA/PE/0000221772
EMA/PE/0000221419
Submitted by Anonymous (not verified) on 16 December 2025 - 10:54
EMA/PE/0000221419
Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (14 November - 11 December 2025)
Submitted by Anonymous (not verified) on 16 December 2025 - 9:36
Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (14 November - 11 December 2025)
Start of procedure: Extension of marketing authorisation (14 November - 11 December 2025)
Submitted by Anonymous (not verified) on 16 December 2025 - 9:33
Start of procedure: Extension of marketing authorisation (14 November - 11 December 2025)
Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025
Submitted by Anonymous (not verified) on 16 December 2025 - 8:52
Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025
New product information wording – Extracts from PRAC recommendations on signals adopted at the 8-11 January 2024 PRAC
Submitted by Anonymous (not verified) on 16 December 2025 - 8:45
New product information wording – Extracts from PRAC recommendations on signals adopted at the 8-11 January 2024 PRAC
New product information wording – Extracts from PRAC recommendations on signals adopted at the 27-30 November 2023 PRAC
Submitted by Anonymous (not verified) on 16 December 2025 - 8:45
New product information wording – Extracts from PRAC recommendations on signals adopted at the 27-30 November 2023 PRAC
Human medicines European public assessment report (EPAR): Coagadex, human coagulation factor X, Date of authorisation: 16/03/2016, Revision: 12, Status: Authorised
Submitted by Anonymous (not verified) on 15 December 2025 - 14:35
Human medicines European public assessment report (EPAR): Coagadex, human coagulation factor X, Date of authorisation: 16/03/2016, Revision: 12, Status: Authorised
ESIM Summer 2026
Submitted by Catalina on 15 December 2025 - 12:23
We are pleased to announce the European Summer School of Internal Medicine (ESIM) 2026!
Following the great success of the previous ESIM Summer School, we are pleased to announce that ESIM Summer 2026 will take place from 31 May to 6 June 2026 at the Astir Egnatia Hotel and the University Hospital of Alexandroupolis, in the beautiful coastal city of Alexandroupolis, Greece.
This will be the second edition of the ESIM Summer School organised by the Hellenic Society of Internal Medicine, under the leadership of Prof. Panagiotis Skendros.
Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 28, Status: Authorised
Submitted by Anonymous (not verified) on 15 December 2025 - 11:36
Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 28, Status: Authorised